MSB 2.10% $1.17 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-186

  1. 130 Posts.
    lightbulb Created with Sketch. 12
    haaaaaaang on haha I think you're jumping the gun there a bit. Heart treatment is still a positive, there is something there. Lower back pain, let's see. This doesn't seem to be a total fail as yet. It's far from 'over' IMO
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.